Evidence map›Paper›PMID 30761009›Full record

ArticleFrontiers in pharmacology2018

A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.

Marie Paule Schneider, Leila Achtari Jeanneret, Bernard Chevaux, Claudine Backes, Anna Dorothea Wagner, Olivier Bugnon, François Luthi, Isabella Locatelli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. The differential impact of a 6-Frontiers in pharmacology · 2024
    Article
  6. Article
  7. Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marie Paule SchneiderCommunity Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
Leila Achtari JeanneretHôpital Neuchâtelois, Neuchâtel, Switzerland.
Bernard ChevauxEtablissements Hospitaliers du Nord Vaudois (eHnv), Yverdon-les-Bains, Switzerland.
Claudine BackesCommunity pharmacy, Department of Ambulatory Care and Primary Medicine, University of Lausanne, Lausanne, Switzerland.
Anna Dorothea WagnerDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Olivier BugnonCommunity Pharmacy, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.
François LuthiHirslanden SA Lausanne, Clinique Bois-Cerf, Lausanne, Switzerland.
Isabella LocatelliDepartment of Ambulatory Care and Primary Medicine, University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

censoringelectronic monitoring (EM)generalized estimating equations (GEE)medication adherence (MeSH)non-persistenceoncologyoral treatmentsroutine care

Identifiers

PMID30761009
PMCPMC6361826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.